Cabinet oks buy of 26% Bazan stake

The Cabinet approved on Sunday a plan for the state to buy Israel Corp.'s 26% stake in Israel Oil Refineries for at least NIS 570m., the Finance Ministry said.

By YIGAL GRAYEFF
November 7, 2005 07:07

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later

The Cabinet approved on Sunday a plan for the state to buy Israel Corp.'s 26% stake in Israel Oil Refineries (Bazan) for at least NIS 570m., the Finance Ministry said. The sale price is based on the average value of two appraisals that took place in June 2003 and is linked to the consumer price index, beginning from July 1, 2003. If the deal does proceed, it will pave the way for the full privatization of Bazan, as this will give the government full ownership of the company and allow it to carry out its plan of separately selling the monopoly's refineries in Ashdod and Haifa.



More about:Israel, Ashdod

Join Jerusalem Post Premium Plus now for just $5 and upgrade your experience with an ads-free website and exclusive content. Click here>>

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection

By GLOBES, NIV ELIS